REGN•benzinga•
Wells Fargo Downgrades Regeneron Pharmaceuticals to Equal-Weight, Lowers Price Target to $580
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 30, 2025 by benzinga